Invitae is a company within the Healthcare category. Invitae is a medical genetics company that specializes in genetic testing for a wide range of clinical applications, including oncology, cardiology, and reproductive health. The company aims to integrate genetic information into routine medical practice by providing comprehensive, high-quality, and affordable testing services. In 2024, the company entered Chapter 11 bankruptcy and sold the majority of its assets to Labcorp.
Invitae was founded in 2010 and is headquartered in San Francisco, CA.
Invitae is rated Emerging on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Invitae is Weak. Significant factual deltas detected. Some AI models omit key brand facts.
AI models classify Invitae as a Under Scrutiny.
Invitae appeared in 4 of 8 sampled buyer-intent queries (50%). While Invitae ranks high for specific medical test queries, the recent bankruptcy and asset sale to Labcorp create significant confusion in AI results regarding the brand's independent future.
AI consensus: High. Models consistently identify Invitae as a medical genetics company focused on making genetic testing affordable and accessible.. Key gap: The primary discrepancy across models involves the brand's current financial status, with some models noting its 2024 Chapter 11 bankruptcy filing while others still describe it as an active, high-growth public entity.
Of 11 key facts verified about Invitae, 9 are well-documented (likely accurate across AI models), 0 have limited sourcing, and 2 are retrieval-dependent and may be inaccurate without live search.
Buyers turn to Invitae for Clinical Diagnosis Only: Patients and providers may rely on medical history and physical exams without specific genetic data., In-house Hospital Labs: Utilizing hospital-based genetic counselors and internal pathology labs to run specialized tests., Specialized Genetics Agencies: Hiring specialized genetic consulting firms to manage testing workflows and interpretation., among 3 documented problem areas.
Buyers evaluating Invitae typically ask AI models about "best medical genetic testing companies", "hereditary cancer screening providers", "affordable pharmacogenomics testing", and 2 similar queries.
Invitae's main competitors are Guardant Health, Labcorp, Myriad Genetics, Inc.. According to AI models, these are the brands most frequently named alongside Invitae in buyer-intent queries.
AI models suggest Clinical Diagnosis Only as alternatives to Invitae, typically when buyers ask for lower-cost, simpler, or more specialized options.
Invitae's core products are Clinical genetic testing (Cancer, Cardiology, Rare Disease, Reproductive Health).
Invitae uses Enterprise/Custom (Insurance billing and patient-pay).
Invitae serves Hospitals, Genetic Counselors, Onclologists, and Patients..
Invitae Initially disrupted the market by offering transparent, flat-fee pricing for comprehensive genetic panels that were previously prohibitively expensive.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Archetype: Under Scrutiny
https://optimly.ai/brand/invitae-invitae
Last analyzed: March 11, 2026
Founded: 2010
Headquarters: San Francisco, California